Healthcare provider profile · identity verified

Debra Phyllis Raffo, NP

Nurse Practitioner · CENTER VALLEY, PA · NPI 1821532912

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	474	94
Eliquis	Apixaban	407	63
Furosemide	Furosemide	403	77
Levothyroxine Sodium	Levothyroxine Sodium	351	54
Amlodipine Besylate	Amlodipine Besylate	337	58
Sertraline Hcl	Sertraline Hcl	337	66
Potassium Chloride	Potassium Chloride	308	60
Pantoprazole Sodium	Pantoprazole Sodium	288	62
Metoprolol Succinate	Metoprolol Succinate	234	46
Gabapentin	Gabapentin	218	55
Tramadol Hcl	Tramadol Hcl	218	57
Lorazepam	Lorazepam	179	59
Losartan Potassium	Losartan Potassium	177	32
Metformin Hcl	Metformin Hcl	166	36
Tamsulosin Hcl	Tamsulosin Hcl	145	26
Quetiapine Fumarate	Quetiapine Fumarate	141	32
Metoprolol Tartrate	Metoprolol Tartrate	139	36
Escitalopram Oxalate	Escitalopram Oxalate	129	22
Lisinopril	Lisinopril	127	24
Duloxetine Hcl	Duloxetine Hcl	113	29
Trazodone Hcl	Trazodone Hcl	101	29
Omeprazole	Omeprazole	96	28
Finasteride	Finasteride	94	15
Torsemide	Torsemide	90	22
Donepezil Hcl	Donepezil Hcl	85	11
Famotidine	Famotidine	85	18
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	85	21
Alprazolam	Alprazolam	83	20
Januvia	Sitagliptin Phosphate	80	suppressed
Clopidogrel	Clopidogrel Bisulfate	79	19
Oxycodone Hcl	Oxycodone Hcl	78	22
Amiodarone Hcl	Amiodarone Hcl	77	13
Clonazepam	Clonazepam	77	19
Simvastatin	Simvastatin	75	13
Mirtazapine	Mirtazapine	72	21
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	70	16
Ondansetron Hcl	Ondansetron Hcl	69	46
Buspirone Hcl	Buspirone Hcl	64	19
Spironolactone	Spironolactone	63	13
Levetiracetam	Levetiracetam	62	12
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	60	33
Oxybutynin Chloride Er	Oxybutynin Chloride	60	suppressed
Prednisone	Prednisone	58	20
Hydralazine Hcl	Hydralazine Hcl	57	14
Myrbetriq	Mirabegron	57	suppressed
Citalopram Hbr	Citalopram Hydrobromide	55	11
Memantine Hcl	Memantine Hcl	55	11
Tradjenta	Linagliptin	55	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	53	suppressed
Carvedilol	Carvedilol	53	13
Morphine Sulfate	Morphine Sulfate	52	24
Hydrochlorothiazide	Hydrochlorothiazide	50	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	48	28
Divalproex Sodium	Divalproex Sodium	46	16
Midodrine Hcl	Midodrine Hcl	43	suppressed
Pregabalin	Pregabalin	43	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	42	29
Aripiprazole	Aripiprazole	40	suppressed
Jardiance	Empagliflozin	40	suppressed
Metolazone	Metolazone	40	suppressed
Pravastatin Sodium	Pravastatin Sodium	40	suppressed
Xarelto	Rivaroxaban	40	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	38	25
Ezetimibe	Ezetimibe	38	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	38	suppressed
Risperidone	Risperidone	38	suppressed
Fluticasone Propionate	Fluticasone Propionate	35	17
Rosuvastatin Calcium	Rosuvastatin Calcium	34	suppressed
Tizanidine Hcl	Tizanidine Hcl	34	11
Divalproex Sodium Er	Divalproex Sodium	33	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	32	suppressed
Cephalexin	Cephalexin	31	23
Latanoprost	Latanoprost	31	11
Olanzapine	Olanzapine	31	11
Atenolol	Atenolol	30	suppressed
Carbamazepine	Carbamazepine	30	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	29	suppressed
Loperamide	Loperamide Hcl	29	11
Novolog Flexpen	Insulin Aspart	27	suppressed
Nystatin	Nystatin	27	19
Methotrexate	Methotrexate Sodium	26	suppressed
Montelukast Sodium	Montelukast Sodium	26	suppressed
Warfarin Sodium	Warfarin Sodium	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	25	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	24	12
Gemtesa	Vibegron	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	16
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Bupropion Hcl	Bupropion Hcl	22	suppressed
Glimepiride	Glimepiride	22	suppressed
Lagevrio (Eua)	Molnupiravir	22	20
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Scopolamine	Scopolamine	22	suppressed
Allopurinol	Allopurinol	21	suppressed
Glipizide	Glipizide	21	suppressed
Lithium Carbonate	Lithium Carbonate	21	suppressed
Azithromycin	Azithromycin	20	17
Bumetanide	Bumetanide	20	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	20	12
Doxazosin Mesylate	Doxazosin Mesylate	20	suppressed
Haloperidol	Haloperidol	20	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	20	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	20	suppressed
Levofloxacin	Levofloxacin	20	17
Mometasone Furoate	Mometasone Furoate	20	suppressed
Paroxetine Hcl	Paroxetine Hcl	20	suppressed
Baclofen	Baclofen	19	suppressed
Hydrocortisone	Hydrocortisone	19	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	19	suppressed
Valsartan	Valsartan	19	suppressed
Admelog Solostar	Insulin Lispro	18	suppressed
Belsomra	Suvorexant	18	suppressed
Fluvoxamine Maleate	Fluvoxamine Maleate	18	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	18	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Morphine Sulfate Er	Morphine Sulfate	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	16	suppressed
Benztropine Mesylate	Benztropine Mesylate	16	suppressed
Incruse Ellipta	Umeclidinium Bromide	16	suppressed
Insulin Aspart Flexpen	Insulin Aspart	16	suppressed
Ketoconazole	Ketoconazole	16	suppressed
Lamotrigine	Lamotrigine	16	suppressed
Terazosin Hcl	Terazosin Hcl	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Chlorhexidine Gluconate	Chlorhexidine Gluconate	15	suppressed
Fluconazole	Fluconazole	15	15
Irbesartan	Irbesartan	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Silodosin	Silodosin	15	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	14	suppressed
Primidone	Primidone	14	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	13	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	13	suppressed
Janumet Xr	Sitagliptin Phos/Metformin Hcl	13	suppressed
Klayesta	Nystatin	13	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	13	suppressed
Meloxicam	Meloxicam	13	suppressed
Sotalol	Sotalol Hcl	13	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	13	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Diazepam	Diazepam	12	suppressed
Levalbuterol Hcl	Levalbuterol Hcl	12	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	12
Novolin 70-30	Insulin Nph Hum/Reg Insulin Hm	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Dabigatran Etexilate	Dabigatran Etexilate Mesylate	11	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	11	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	11	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	11	suppressed
Pacerone	Amiodarone Hcl	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	11	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error